
Throxy, a UK-based outbound growth partner for companies targeting traditional industries, has raised €5.3M in Seed funding to scale its outcome-based model where clients only pay if meetings are booked. The round was led by Base10 Partners, with participation from Y Combinator.
SUMMARY
- Throxy, a UK-based outbound growth partner for companies targeting traditional industries, has raised €5.3M in Seed funding to scale its outcome-based model where clients only pay if meetings are booked. The round was led by Base10 Partners, with participation from Y Combinator.
Pablo Jiménez de Parga Ramos, Co-founder at Throxy, said: “Outbound sales has stagnated over the past decade, with rapidly diminishing returns. Likewise, generic automation tools – even those promising the wizardry of AI – aren’t penetrating traditional industries because they don’t know how to find relevant prospects, let alone target them effectively.”
Founded in 2023 by Pablo Jiménez de Parga Ramos, Bergen Merey, and Arnau Ayerbe, Throxy was created to remove sales bottlenecks and burnout faced by global companies.
Read Also - Spanish Startup Supersonik Launches From Stealth And Raises €4.2 Million Funding
RECOMMENDED FOR YOU

Cologne-based specter automation Secures over €5 Million in extended Seed Funding
Kailee Rainse
Mar 27, 2025

Elbow Beach funding news – London-based Elbow Beach Announces New Climate Impact Fund With £63Mn
Kailee Rainse
Mar 22, 2025

Atomik AM Funding News- British Startup Atomik AM Secures €713k Funding To Scale Its Business
Kailee Rainse
May 23, 2025
With experience running outbound from zero-revenue startups to Series D leaders, the founders refined Throxy’s model internally to grow their own pipeline before rolling it out to clients. This approach helped the company reach €1.2M ARR with just three people. Backed by fresh funding and a recent Y Combinator graduation, Throxy plans to expand its team nearly fivefold.
Throxy targets industries like medical, logistics, and manufacturing sectors where buyers are hard to find and traditional or AI-driven sales tools fall short. Sales teams in these industries lose up to 70% of their time on repetitive prospecting instead of closing deals, creating a feast-or-famine cycle.
Throxy solves this by blending proprietary data, custom technology, and human expertise to uncover overlooked prospects and automate outreach. Its outcome-based model means clients only pay if meetings are booked.
Customers include Imnoo, an AI-powered quoting tool for CNC manufacturers, which used Throxy to automate outbound and consistently secure 3–5 qualified meetings per week.
“The manufacturing industry is one of the toughest markets to crack, it’s complex and relationship driven. With Throxy as our partner, we’re starting real conversations with prospects we know will be interested, so our team can focus on closing deals,” comments Niklas Gerlach, COO at Imnoo.
Throxy’s approach is gaining traction with companies selling high-value contracts in hard-to-reach sectors. Clients in manufacturing, education, and healthcare including Imnoo, Santillana, and Pycad report strong results, such as 84% positive reply rates and saving more than 15 hours per week on outbound efforts.
“Throxy isn’t another AI sales tool. It’s an execution layer for growth in industries tech often forgets, which resonates strongly with our thesis on backing founders building for the 99%,” said Rexhi Dollau, General Partner at Base10 Partners. “We’re proud to be partnering with Throxy, a company delivering real outcomes, not just activity.”
About Throxy
Throxy manages the entire outbound process deliverability, list building, decision-maker targeting, and expert outreach so your team can concentrate on closing deals. They deliver high-quality results with your ideal customers while keeping your sales process simple, efficient, and free from unnecessary complexity, ensuring faster growth and stronger sales outcomes.
Recommended Stories for You

Epoch BioDesign funding news – Epoch BioDesign Secures $18.3 Million in Series A Round Funding
Kailee Rainse Mar 5, 2025